RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tianjin Pharmaceutical Da Ren Tang Group Corp Stock

Tianjin Pharmaceutical Da Ren Tang Group Corp Employees 2024

Tianjin Pharmaceutical Da Ren Tang Group Corp Employees

4,720

Ticker

600329.SS

ISIN

CNE000001808

In 2024, Tianjin Pharmaceutical Da Ren Tang Group Corp employed 4,720 people, a 0% change from the 4,720 number of employees in the previous year.

Tianjin Pharmaceutical Da Ren Tang Group Corp Aktienanalyse

What does Tianjin Pharmaceutical Da Ren Tang Group Corp do?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is one of the leading pharmaceutical companies in China. It was founded in 1994 and is headquartered in the city of Tianjin in the northern part of the country. Zhongxin is a publicly traded company and employs over 6,000 employees. The business model of Zhongxin is diversified and includes manufacturing, research and development, sales, and marketing of pharmaceuticals and medical devices. The company strives to provide its customers with high-quality products and services and operates in various specialized areas. One of Zhongxin's main divisions is the manufacturing of pharmaceutical products. The company specializes in the production of cardiology, gastroenterology, oncology, and traditional Chinese medicines. Zhongxin operates multiple production facilities in China and has a productive R&D department focused on drug development. Another important part of Zhongxin's business is the distribution of its products. The company operates several distribution centers in China and is also increasing its presence in international markets. Distribution is done either directly to end customers or through intermediaries. In addition to the sale of medications, Zhongxin is also involved in medical wholesale activities, including retail and delivery of medical equipment and instruments. The company is capable of providing all types of medical devices and instruments from imaging and diagnostics to surgical instruments and implants. Zhongxin also has a specialized chemicals and raw materials division focused on the production of pharmaceutical active ingredients and intermediates. This gives the company additional control over the quality of its products as it is able to produce raw materials itself. The company is always seeking new innovations and heavily investing in research and development. In recent times, Zhongxin has invested in the development of biotech and nucleic acid therapies and intends to develop further innovative treatment methods. Zhongxin has also developed a strong presence in international markets in recent years. It has subsidiaries in several countries including the USA, Australia, Japan, and Europe. The company engages in joint ventures and strategic partnerships to enhance its raw material procurement and expand its reach internationally. Overall, Tianjin Zhongxin Pharmaceutical Group Corp Ltd is a significant player in the pharmaceutical industry in China and on the international stage. The company has established a reputation as a reliable producer of high-quality medical products and services and continues to strive for success through innovation and expansion. Tianjin Pharmaceutical Da Ren Tang Group Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Tianjin Pharmaceutical Da Ren Tang Group Corp's Employee Base

Tianjin Pharmaceutical Da Ren Tang Group Corp's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Tianjin Pharmaceutical Da Ren Tang Group Corp's operational capacity and future potential.

Year-to-Year Comparison

Assessing Tianjin Pharmaceutical Da Ren Tang Group Corp's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Tianjin Pharmaceutical Da Ren Tang Group Corp's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Tianjin Pharmaceutical Da Ren Tang Group Corp’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Tianjin Pharmaceutical Da Ren Tang Group Corp stock

How many employees does Tianjin Pharmaceutical Da Ren Tang Group Corp have this year?

Tianjin Pharmaceutical Da Ren Tang Group Corp has 4,720 undefined employees this year.

How many employees did Tianjin Pharmaceutical Da Ren Tang Group Corp have compared to the previous year?

Compared to the previous year, Tianjin Pharmaceutical Da Ren Tang Group Corp had 0% more employees.

What impact did the number of employees have on the company Tianjin Pharmaceutical Da Ren Tang Group Corp?

The number of employees has a direct impact on the efficiency and productivity of Tianjin Pharmaceutical Da Ren Tang Group Corp. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The number of employees can also have an impact on investors of Tianjin Pharmaceutical Da Ren Tang Group Corp, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Tianjin Pharmaceutical Da Ren Tang Group Corp affect the company?

An increase in equity of Tianjin Pharmaceutical Da Ren Tang Group Corp can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Tianjin Pharmaceutical Da Ren Tang Group Corp's equity affect the company?

A reduction in equity of Tianjin Pharmaceutical Da Ren Tang Group Corp can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Tianjin Pharmaceutical Da Ren Tang Group Corp?

Some factors that can influence the equity of Tianjin Pharmaceutical Da Ren Tang Group Corp include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Tianjin Pharmaceutical Da Ren Tang Group Corp so important for investors?

The equity of Tianjin Pharmaceutical Da Ren Tang Group Corp is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Tianjin Pharmaceutical Da Ren Tang Group Corp influence the company?

The number of employees at Tianjin Pharmaceutical Da Ren Tang Group Corp can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Tianjin Pharmaceutical Da Ren Tang Group Corp evolved in recent years?

In recent years, the number of employees at Tianjin Pharmaceutical Da Ren Tang Group Corp has changed by 0.

How many employees does Tianjin Pharmaceutical Da Ren Tang Group Corp currently have?

Tianjin Pharmaceutical Da Ren Tang Group Corp currently has 4,720 undefined employees.

Why is the number of employees important for investors of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The number of employees is important for investors of Tianjin Pharmaceutical Da Ren Tang Group Corp as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Tianjin Pharmaceutical Da Ren Tang Group Corp take to change the number of employees?

To change the number of employees, Tianjin Pharmaceutical Da Ren Tang Group Corp can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Tianjin Pharmaceutical Da Ren Tang Group Corp pay?

Over the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group Corp paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tianjin Pharmaceutical Da Ren Tang Group Corp is expected to pay a dividend of 1.21 CNY.

What is the dividend yield of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The current dividend yield of Tianjin Pharmaceutical Da Ren Tang Group Corp is .

When does Tianjin Pharmaceutical Da Ren Tang Group Corp pay dividends?

Tianjin Pharmaceutical Da Ren Tang Group Corp pays a quarterly dividend. This is distributed in the months of July, July, July, August.

How secure is the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Pharmaceutical Da Ren Tang Group Corp paid dividends every year for the past 16 years.

What is the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp?

For the upcoming 12 months, dividends amounting to 1.21 CNY are expected. This corresponds to a dividend yield of 4.58 %.

In which sector is Tianjin Pharmaceutical Da Ren Tang Group Corp located?

Tianjin Pharmaceutical Da Ren Tang Group Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tianjin Pharmaceutical Da Ren Tang Group Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp from 7/12/2024 amounting to 1.28 CNY, you needed to have the stock in your portfolio before the ex-date on 7/12/2024.

When did Tianjin Pharmaceutical Da Ren Tang Group Corp pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp in the year 2023?

In the year 2023, Tianjin Pharmaceutical Da Ren Tang Group Corp distributed 0.5 CNY as dividends.

In which currency does Tianjin Pharmaceutical Da Ren Tang Group Corp pay out the dividend?

The dividends of Tianjin Pharmaceutical Da Ren Tang Group Corp are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tianjin Pharmaceutical Da Ren Tang Group Corp

Our stock analysis for Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.